Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Background There is controversy regarding the optimal renal-replacement therapy (RRT) modality for critically ill patients with acute kidney injury (AKI). Methods We conducted a secondary analysis of the STandard versus Accelerated Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial to compare outcomes among patients who initiated RRT with either continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD). We generated a propensity score for the likelihood of receiving CRRT and used inverse probability of treatment with overlap-weighting to address baseline inter-group differences. The primary outcome was a composite of death or RRT dependence at 90-days after randomization. Results We identified 1590 trial participants who initially received CRRT and 606 who initially received IHD. The composite outcome of death or RRT dependence at 90-days occurred in 823 (51.8%) patients who commenced CRRT and 329 (54.3%) patients who commenced IHD (unadjusted odds ratio (OR) 0.90; 95% confidence interval (CI) 0.75–1.09). After balancing baseline characteristics with overlap weighting, initial receipt of CRRT was associated with a lower risk of death or RRT dependence at 90-days compared with initial receipt of IHD (OR 0.81; 95% CI 0.66–0.99). This association was predominantly driven by a lower risk of RRT dependence at 90-days (OR 0.61; 95% CI 0.39–0.94). Conclusions In critically ill patients with severe AKI, initiation of CRRT, as compared to IHD, was associated with a significant reduction in the composite outcome of death or RRT dependence at 90-days..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:49

Enthalten in:

Intensive care medicine - 49(2023), 11 vom: 10. Okt., Seite 1305-1316

Sprache:

Englisch

Beteiligte Personen:

Wald, Ron [VerfasserIn]
Gaudry, Stephane [VerfasserIn]
da Costa, Bruno R. [VerfasserIn]
Adhikari, Neill K. J. [VerfasserIn]
Bellomo, Rinaldo [VerfasserIn]
Du, Bin [VerfasserIn]
Gallagher, Martin P. [VerfasserIn]
Hoste, Eric A. [VerfasserIn]
Lamontagne, François [VerfasserIn]
Joannidis, Michael [VerfasserIn]
Liu, Kathleen D. [VerfasserIn]
McAuley, Daniel F. [VerfasserIn]
McGuinness, Shay P. [VerfasserIn]
Nichol, Alistair D. [VerfasserIn]
Ostermann, Marlies [VerfasserIn]
Palevsky, Paul M. [VerfasserIn]
Qiu, Haibo [VerfasserIn]
Pettilä, Ville [VerfasserIn]
Schneider, Antoine G. [VerfasserIn]
Smith, Orla M. [VerfasserIn]
Vaara, Suvi T. [VerfasserIn]
Weir, Matthew [VerfasserIn]
Dreyfuss, Didier [VerfasserIn]
Bagshaw, Sean M. [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Acute kidney injury
Continuous
Intermittent hemodialysis
Modality
Mortality
Randomized trial
Renal-replacement therapy

Anmerkungen:

© Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s00134-023-07211-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR053605705